Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Research Reports
    3. >Pain Management Drugs Market Growth, Top Companies, Sales, Revenue Analysis and Forecast 2021-2026
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Research Reports

    Pain Management Drugs Market Growth, Top Companies, Sales, Revenue Analysis and Forecast 2021-2026

    Published by IMARC Services Private Limited

    Posted on September 9, 2021

    4 min read

    Last updated: February 12, 2026

    Add as preferred source on Google
    This image represents the luxury fashion industry, highlighting Capri Holdings' plans to increase prices for Michael Kors and Versace in response to booming consumer demand. The article discusses Capri's strong sales growth and brand repositioning strategies.
    Luxury fashion brands Michael Kors and Versace logo showcasing price increases amidst booming demand - Global Banking & Finance Review
    Tags:healthcareMarket analysisinvestmentresearch

    Growth Forecast for Pain Management Drugs Market: Key Insights 2021-2026

    The latest report by IMARC Group, titled “Pain Management Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The global pain management drugs market reached a value of US$ 74 Billion in 2020.  Looking forward, IMARC Group expects the global pain management drugs market to exhibit moderate growth during the forecast period (2021-2026). Pain management drugs are a set of medications that are used for reducing or treating the pain associated with a disease, injury or surgery. These drugs provide relief by acting through distinctive physiological mechanisms. The management of pain remains of high relevance across a broad spectrum of medical fields as it is one of the most common concerns for physicians while dealing with severe medical conditions. Owing to this, pain management medicines have evolved into a large specialty area over the years.

    Request Free Sample Report: https://www.imarcgroup.com/pain-management-drugs-market/requestsample

    As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

    Market Trends:

    The increasing prevalence of chronic conditions, such as lower back pain, post-operative pain, osteoarthritis and migraine headache, is the primary factor for the increase in the sales of pain management drugs across the globe. Also, these painkillers help the rising number of cancer patients to minimize pain during chemotherapy, radiotherapy, and surgeries involved in the treatment. Apart from this, governments of various nations are also providing funds to improve healthcare services. This has led to several medical advancements, resulting in the introduction of novel molecule combinations and newer drug delivery techniques. Moreover, the leading pharmaceutical companies are heavily investing in research and development (R&D) activities to develop analgesics that are safer, more effective, economically viable and easier to administer.

    Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/pain-management-drugs-market

    Key Market Segmentation:

    Competitive Landscape With Key Players :

    •  Abbott Laboratories, Inc
    • Pfizer, Inc.
    • Eli Lilly & Company
    • Endo International plc
    • F. Hoffmann-La Roche AG
    • Bausch Health Companies, Inc.
    • Merck & Co. Inc.
    • Allergen Inc.
    • Novartis International AG
    • Johnson & Johnson Private Limited
    • GlaxoSmithKline Plc
    • Purdue Pharma L.P.

    Market Breakup by Drug Class:

    • NSAIDs
    • Anesthetics
    • Anticonvulsants
    • Antimigraine Agents
    • Antidepressants
    • Opioids
    • Others

    Market Breakup by Indication:

    • Musculoskeletal Pain
    • Surgical and Trauma Pain
    • Cancer Pain
    • Neuropathic Pain
    • Migraine Pain
    • Obstetrical Pain
    • Fibromyalgia Pain
    • Burn Pain
    • Dental/Facial Pain
    • Pediatric Pain
    • Others

    Market Breakup by Distribution Channel:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

    Breakup by Region:

    • North America (United States, Canada)
    • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
    • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
    • Latin America (Brazil, Mexico, Others)
    • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

    Key highlights of the report:

    • Market Performance
    • Market Outlook
    • Porter’s Five Forces Analysis
    • Market Drivers and Success Factors
    • SWOT Analysis
    • Value Chain
    • Competitive Structure
    • Profiles of Key Players

    Note- We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

    About Us:

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

    Contact Us:
    IMARC Group
    30 N Gould St Ste R
    Sheridan, WY 82801 USA
    Email: Sales@imarcgroup.com
    Tel No:(D) +91 120 433 0800 | www.imarcgroup.com
    Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

    Other Reports by IMARC Group:

    Generic Drug Market: https://www.imarcgroup.com/generic-drug-manufacturing-plant

    Ceramic Ball Bearings Market: https://www.imarcgroup.com/ceramic-ball-bearings-market

    Takaful Market: https://www.imarcgroup.com/takaful-market

    Battery Charger Market: https://www.imarcgroup.com/battery-charger-market

    Solar Generator Market: https://www.imarcgroup.com/solar-generator-market

    Generic Injectables Market: https://www.imarcgroup.com/generic-injectables-market

    Lithography Systems Market: https://www.imarcgroup.com/lithography-systems-market

    Colostomy Bags Market: https://www.imarcgroup.com/colostomy-bags-market

    Silicones and Siloxanes Market: https://www.imarcgroup.com/silicone-siloxane-market

    Frequently Asked Questions about Pain Management Drugs Market Growth, Top Companies, Sales, Revenue Analysis and Forecast 2021-2026

    1What factors are driving the growth of the pain management drugs market?

    The increasing prevalence of chronic conditions, such as lower back pain, post-operative pain, osteoarthritis, and migraine headaches, is the primary factor driving the sales of pain management drugs.

    2
    What is the forecast period for the pain management drugs market?

    The pain management drugs market is forecasted to grow from 2021 to 2026, according to the latest report by IMARC Group.

    3Who are the key players in the pain management drugs market?

    The report provides a competitive landscape featuring key players in the pain management drugs market, though specific names are not mentioned in the provided content.

    4How can I access the full report on the pain management drugs market?

    You can download the full report, including the table of contents and list of figures, from the IMARC Group's website.

    5What are the main drug classes in the pain management drugs market?

    The market is segmented by drug class, although specific classes are not detailed in the provided content.

    More from Research Reports

    Explore more articles in the Research Reports category

    Image for Workflow Automation Market Outlook 2025: Business Expansion, Market Trends, and Future Predictions
    Workflow Automation Market Outlook 2025: Business Expansion, Market Trends, and Future Predictions
    Image for Smart Contracts Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
    Smart Contracts Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
    Image for Predictive Maintenance Market 2025-2032: Industry Outlook, Trends Analysis, New Opportunities, and Prospects
    Predictive Maintenance Market 2025-2032: Industry Outlook, Trends Analysis, New Opportunities, and Prospects
    Image for Oilseed Market to Expand at a CAGR of 5.3% by 2032 – Growth Drivers & Forecast Analysis
    Oilseed Market to Expand at a Cagr of 5.3% by 2032 – Growth Drivers & Forecast Analysis
    Image for Offshore Decommissioning Market Predicted to Reach USD 12.27 Billion by 2032, Growing at a CAGR of 6.3% | Coherent Market Insights
    Offshore Decommissioning Market Predicted to Reach Usd 12.27 Billion by 2032, Growing at a Cagr of 6.3% | Coherent Market Insights
    Image for Flea And Tick Products Market Anticipated to flourish at a CAGR of 9.32% from 2025 to 2032
    Flea and Tick Products Market Anticipated to Flourish at a Cagr of 9.32% From 2025 to 2032
    Image for Customer Data Platform Market Growth Probability, Key Vendors and Future Scenario Up To 2032
    Customer Data Platform Market Growth Probability, Key Vendors and Future Scenario up to 2032
    Image for Carbon Dioxide Utilization Market to Hit $14.38 Bn by 2032 with a CAGR of 13.6% According to Coherent Market Insights
    Carbon Dioxide Utilization Market to Hit $14.38 Bn by 2032 With a Cagr of 13.6% According to Coherent Market Insights
    Image for Beauty Supplements Market Anticipated to flourish at a CAGR of 5.55% from 2025 to 2032, reaching USD 4,591 Million by 2032
    Beauty Supplements Market Anticipated to Flourish at a Cagr of 5.55% From 2025 to 2032, Reaching Usd 4,591 Million by 2032
    Image for AI Governance Market Size & Forecast 2025-2032 : Emerging Business Opportunities and Growth Prospects
    AI Governance Market Size & Forecast 2025-2032 : Emerging Business Opportunities and Growth Prospects
    Image for Wireline Services Market to Reach USD 47.13 Billion by 2032 with a 7.0% CAGR According to Coherent Market Insights
    Wireline Services Market to Reach Usd 47.13 Billion by 2032 With a 7.0% Cagr According to Coherent Market Insights
    Image for U.S. Hospitality Staffing Market to be Worth USD 258.72 Billion by 2032: Coherent Market Insights
    U.S. Hospitality Staffing Market to Be Worth Usd 258.72 Billion by 2032: Coherent Market Insights
    View All Research Reports Posts
    Previous Research Reports PostRefrigerated Transport Market Trends, Demand, Industry Size, Future Growth and Opportunities During 2021-2026
    Next Research Reports PostMhealth Solutions Market Growth Opportunities 2021-2027